These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8137488)

  • 1. Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.
    Ichida T; Kato M; Hayakawa A; Ito S; Mori S; Sato T; Sugitani S; Sato H; Watanabe M; Asakura H
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S74-8. PubMed ID: 8137488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study.
    Ichida T; Kato M; Hayakawa A; Watanabe M; Igarashi K; Hata K; Doya Y; Miura M; Sato H; Asakura H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S51-4. PubMed ID: 1281045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
    Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma.
    Yodono H; Matsuo K; Shinohara A
    Anticancer Drugs; 2011 Mar; 22(3):277-82. PubMed ID: 21360850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
    Kanematsu M
    J Gastroenterol; 1995 Apr; 30(2):215-23. PubMed ID: 7773353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma.
    Tzeng WS; Wu RH; Chang SC; Chou CK; Lin CY; Chen JJ; Yang SC; Lin CH
    J Vasc Interv Radiol; 2008 Mar; 19(3):342-50. PubMed ID: 18295692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
    Aoyama K; Tsukishiro T; Okada K; Tsuchida T; Aiba N; Nambu S; Miyabayashi C; Yasuyama T; Higuchi K; Watanabe A
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S55-9. PubMed ID: 1281046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.
    Iwamiya T; Sawada S; Ohta Y
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S134-8. PubMed ID: 8137474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of therapeutic effects of cisplatin-phosphatidyl-choline-lipiodol (CPL) suspension for hepatocellular carcinoma].
    Sakata K; Hirai K; Izyuin H; Noguchi H; Ono N; Aoki Y; Tanikawa K; Okano Y; Tomita Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1847-50. PubMed ID: 1652224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S; Novell JR; Dusheiko GM; Hilson AJ; Dick R; Hobbs KE
    Cancer; 1995 Dec; 76(11):2202-10. PubMed ID: 8635022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
    Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G
    J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
    Tarusawa K; Yodono H; Ikami I; Sasaki T; Kanehira J; Takahashi S; Shibutani K; Noda H; Shinohara A; Takekawa D
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):383-6. PubMed ID: 1311915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin].
    Bokemeyer B; Grote R; Schmoll E; Freise J; Schmoll HJ; Galanski M; Schüler A; Schmidt FW
    Dtsch Med Wochenschr; 1989 Jan; 114(4):128-32. PubMed ID: 2536606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)].
    Onohara S; Ogita M; Shimada J; Hiraki Y; Abeyama K; Nakajo M
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):315-21. PubMed ID: 1311912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of concentrated CDDP-lipiodol emulsion for hepatic arterial infusion therapy in patients with nonresectable hepatoma].
    Nakashima K; Iwao Y; Suzuki K; Tada I; Kim YI; Kobayashi M; Mori K; Takayama F; Takeyama M; Aikawa H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1731-5. PubMed ID: 2167645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma.
    Yamamoto K; Shimizu T; Narabayashi I
    Cardiovasc Intervent Radiol; 2000; 23(1):26-39. PubMed ID: 10656904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.